No Data
No Data
Benitec Biopharma Welcomes Kishan Mehta to Its Board
Express News | Benitec Biopharma Announces Appointment of Kishen Mehta to Its Board of Directors
Piper Sandler Starts Benitec at Overweight, Cites BB-301 Opportunity
Benitec Biopharma Initiated at Overweight by Piper Sandler
Benitec Biopharma Initiated at Overweight by Piper Sandler
Piper Sandler Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $30
Piper Sandler analyst Yasmeen Rahimi initiates coverage on $Benitec Biopharma(BNTC.US)$ with a buy rating, and sets the target price at $30.According to TipRanks data, the analyst has a success rate o
Express News | Piper Sandler Initiates Coverage On Benitec Biopharma With Overweight Rating, Announces Price Target of $30
No Data